Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies.

@article{Kanhai2013AdiponectinAI,
  title={Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies.},
  author={Danny A Kanhai and Mariette E G Kranendonk and C Uiterwaal and Y van der Graaf and L. Jaap Kappelle and Frank L. J. Visseren},
  journal={Obesity reviews : an official journal of the International Association for the Study of Obesity},
  year={2013},
  volume={14 7},
  pages={
          555-67
        }
}
The plasma concentration of adiponectin, an adipokine that has anti-inflammatory, anti-atherogenic and insulin sensitizing properties, is lower in obese subjects and could therefore be a target for therapy. In order to review and meta-analyse prospective cohort studies investigating adiponectin concentration and the risk for incident coronary heart disease (CHD) or stroke, a systematic search of MEDLINE, EMBASE and Cochrane databases was performed. Two independent reviewers selected prospective… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS

Serum parathyroid hormone as a potential novel biomarker of coronary heart disease.

  • Genetic testing and molecular biomarkers
  • 2014
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Serum adiponectin levels and risk of cardiovascular disease.

  • Aging clinical and experimental research
  • 2018
VIEW 3 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS

Adipokines and cardiovascular disease: A comprehensive review.

  • Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 57 REFERENCES

Adiponectin and risk of coronary heart disease in older men and women.

  • The Journal of clinical endocrinology and metabolism
  • 2008
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…